​

Metagenomi (MGX) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChart

MGX Stock Forecast

Metagenomi (MGX) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $7.00, with a high of $7.00 and a low of $7.00. This represents a 164.15% increase from the last price of $2.65.

$1 $3 $5 $7 $9 $11 $12 High: $7 Avg: $7 Low: $7 Last Closed Price: $2.65

MGX Stock Rating

Metagenomi stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

MGX Forecast vs Benchmarks

TypeNameUpside
StockMetagenomi164.15%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$14.50
Last Closing Price$2.65$2.65$2.65
Upside/Downside--447.17%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25141--6
Dec, 24241--7
Nov, 24251--8
Oct, 24251--8
Sep, 24251--8
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 21, 2024Mitchell KapoorH.C. Wainwright$7.00$3.30112.12%164.15%
Mar 28, 2024Maury RaycrofJefferies$22.00$11.0998.38%730.19%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2024H.C. WainwrightBuyBuyhold
Sep 04, 2024Cowen & Co.BuyBuyhold
Aug 21, 2024H.C. WainwrightBuyBuyhold
May 07, 2024H.C. WainwrightBuyinitialise
Mar 28, 2024JefferiesBuyBuyhold

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.82-----
Avg Forecast$-19.54$-2.48$-2.66$-2.38$-3.70$-3.60
High Forecast$-28.61$-2.67$-3.80$-4.33$-4.18$-7.03
Low Forecast$-4.92$-2.19$-1.10$-0.22$-3.22$-0.70
Surprise %-90.69%-----

Revenue Forecast

$0 $12M $24M $36M $48M $60M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$44.76M-----
Avg Forecast$44.68M$51.81M$34.11M$40.24M$10.00M$10.00M
High Forecast$42.06M$46.44M$15.37M$40.18M$3.80M$3.80M
Low Forecast$47.30M$59.70M$55.86M$40.30M$17.33M$17.33M
Surprise %0.17%-----

Net Income Forecast

$-2B $-1B $-900M $-600M $-300M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-68.25M-----
Avg Forecast$-629.26M$-91.13M$-112.09M$-151.26M$-138.91M$-135.16M
High Forecast$-1.07B$-100.21M$-142.70M$-162.54M$-156.94M$-263.89M
Low Forecast$-184.82M$-82.06M$-41.23M$-8.13M$-120.89M$-26.28M
Surprise %-89.15%-----

MGX Forecast FAQ

Is Metagenomi stock a buy?

Metagenomi stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Metagenomi is a favorable investment for most analysts.

What is Metagenomi's price target?

Metagenomi's price target, set by 3 Wall Street analysts, averages $7 over the next 12 months. The price target range spans from $7 at the low end to $7 at the high end, suggesting a potential 164.15% change from the previous close price of $2.65.

How does Metagenomi stock forecast compare to the average forecast of its sector, industry, and investment themes?

Metagenomi stock forecast shows a 164.15% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Metagenomi over the past three months?

  • January 2025: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 28.57% Strong Buy, 57.14% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Metagenomi’s EPS forecast?

Metagenomi's average annual EPS forecast for its fiscal year ending in December is -2.48 for 2024, a 36.26% increase from the reported $-1.82 in 2023. The prediction for 2025 is $-2.66, $-2.38 for 2026, $-3.7 for 2027, and $-3.6 for 2028.

What is Metagenomi’s revenue forecast?

Metagenomi's average annual revenue forecast for its fiscal year ending in December is $51.81M for 2024, a 15.76% increase from the reported $44.76M in 2023. The forecast for 2025 is $34.11M, $40.24M for 2026, $10M for 2027, and $10M for 2028.

What is Metagenomi’s net income forecast?

For its fiscal year ending in December, Metagenomi's average annual net income forecast is $-91.132M for 2024, reflecting an 33.52% increase from the reported $-68.255M in 2023. The projection for 2025 is $-112M, $-151M for 2026, $-139M for 2027, and $-135M for 2028.